CAE

Consider This Before Taking a Position in CAE (CAE)

Mid-cap industrials company CAE has moved 2.0% Friday, reaching $22.05 per share. In contrast, the average analyst target price for the stock is $25.94.

CAE Inc., together with its subsidiaries, provides simulation training and critical operations support solutions worldwide. The company is based in Canada.

What to Consider if You Are Thinking of Buying CAE:

  • CAE has moved -11.7% over the last year.

  • CAE has a forward P/E ratio of 24.8 based on its EPS guidance of 0.89.

  • Over the last 3 years, earnings per share (EPS) have been growing at a compounded average rate of -28.7%.

  • The company has a price to earnings growth (PEG) ratio of 3.8.

  • Its Price to Book (P/B) ratio is 1.6

CAE Has Generally Positive Cash Flows

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cashflow ($ k) YoY Growth (%)
2022-03-31 418,200 -362,800 55,400 -72.71
2021-03-31 366,600 -163,600 203,000 26.01
2020-03-31 545,100 -384,000 161,100 n/a

CAE's free cash flows are strong in the aggregate, since they average out to $139.83 Million over the last 3 years. But they are highly variable since their coefficient of variability is 54.4%. The compounded average growth rate for this period stands at -29.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS